MEDGENE THERAPEUTICS
MedGene Therapeutics is focused on developing ACT treatments (PMBC derived tumor-reactive T cells-Natural Unmodified CD8+ lymphocytes) for two cancers—MSTS (metastatic soft tissue sarcoma) and MFTC (metastatic follicular thyroid cancer)—using NIH patented technology with Worldwide Exclusive License Agreement of commercialization.
MEDGENE THERAPEUTICS
Industry:
Biotechnology Health Care Health Diagnostics
Founded:
2015-01-01
Address:
Silver Spring, Maryland, United States
Country:
United States
Status:
Active
Contact:
(301) 500-6746
Total Funding:
1.15 M USD
Similar Organizations
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Fulcrum Therapeutics
Fulcrum Therapeutics is a biotechnology company that develops new medicines to treat patients with rare genetic diseases.
Eden Biologics
Eden Biologics is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners.
Current Employees Featured
Founder